← Back to patent-cliff list
CAS 1313020-26-6
isopropyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
Codes: BENDAM-001
Application context (from source-drug indications)
B-cell lymphomaBendamustine HydrochlorideNon-Hodgkin lymphomaBendamustine HydrochlorideChronic lymphocytic leukaemiaBendamustine HydrochlorideMantle cell lymphomaBendamustine HydrochlorideLymphomaBendamustine HydrochlorideMultiple myelomaBendamustine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Bendamustine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
isopropyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate→2-chloroethan-1-ol→isopropyl 4-(5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate→isopropyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate→Bendamustine Hydrochloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.